Harness Dickey
  • COVID-19 IP Update
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation.  Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.

  • Chemistry & Nanotechnology

      ALL CATEGORIES

      • Biologics & Biosimilars
        • Antitrust Issues
        • Competitor Dynamics
        • FDA Guidance & Updates
        • Interchangeability
      • BioPharma
      • Chemistry & Nanotechnology
      • COVID-19 IP Update
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
      • Uncategorized
  • All Years
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Jewell N. BriggsJewell N. Briggs 8
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 1
    • William J. CoughlinWilliam J. Coughlin 1
    • Matthew L. CutlerMatthew L. Cutler 15
    • Donald J. DaleyDonald J. Daley 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Glenn E. ForbisGlenn E. Forbis 11
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Michael P. KellaMichael P. Kella 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 10
    • Damian H. Kotsis, Ph.D.Damian H. Kotsis, Ph.D. 4
    • Kisuk LeeKisuk Lee 1
    • Robert J. LenihanRobert J. Lenihan 1
    • Chris K. MillerChris K. Miller 1
    • Michael R. NyeMichael R. Nye 4
    • Joshua A. PartingtonJoshua A. Partington 4
    • Leanne M. RakersLeanne M. Rakers 15
    • Douglas A. RobinsonDouglas A. Robinson 15
    • Joel R. SamuelsJoel R. Samuels 15
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 15
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3
  • Close up image of a brown and tan dog's face and snout

    October 9, 2020

    Proper IP Management Gives Pet Food Manufacturers a Competitive Edge

    More

  • September 25, 2020

    Finding Claims Non-obvious Was Not Error, It Was the Application of the Proper Evidentiary Standard

    More

  • September 24, 2020

    IPR Estoppel: It’s Not A Second Bite at the Apple if You Didn’t Get a First Bite

    More

  • September 17, 2020

    Like a Phoenix (Digitally) Arising from the Ashes: Newly Digitized 1837-1847 U.S. Patents

    More

  • IP Litigation and Contested Matters

    September 5, 2020

    §315(c) Does Not Allow Board to Join IPRs or to Add Issues to an IPR via Joinder

    More

  • Harness Dickey Trademark Attorneys St. Louis Detroit Dallas Washington, DC

    August 30, 2020

    Goodwill Hunting

    More

June 19, 2017

Missed opportunity: Federal Circuit Again Offers No Clarifying Insight on Alice’s Two-Step Framework

By: Jewell N. Briggs, Associate

April 28, 2017

Ready, Set, Nano-Race!

By: Jennifer M. Woodside Wojtala, Principal

Chemical Patents Image

March 2, 2017

Chemistry & Nanotechnology Developments to Watch in 2017

By: Jennifer M. Woodside Wojtala, Principal; Leanne M. Rakers, Principal

Harness Dickey Biopharma Patent Law

February 9, 2017

2016’s Top Patent and Trade Secret Developments for Chemistry and Nanotechnology

By: David L. Suter, Principal; Jennifer M. Woodside Wojtala, Principal; Jewell N. Briggs, Associate; Damian H. Kotsis, Ph.D., Associate; Jennifer R. Turchyn, Associate

Harness Dickey Biopharma Patent Law

February 9, 2017

USPTO Claim Construction Standards for Inter Partes Review Proceedings

By:

Harness Dickey Biopharma Patent Law

February 9, 2017

USPTO Standards of Review for Inter Partes Review Proceedings

By:

Harness Dickey Biopharma Patent Law

February 9, 2017

USPTO Errs in Failing to Carry Burden to Support Rejection

By:

Harness Dickey Biopharma Patent Law

February 9, 2017

On-Sale Bar for Contractor and Supplier Activities

By: Jennifer M. Woodside Wojtala, Principal; Jason A. Heist, Principal

Harness Dickey Biopharma Patent Law

February 9, 2017

Federal Trade Secrets Act

By: Jennifer M. Woodside Wojtala, Principal; David L. Suter, Principal; Jewell N. Briggs, Associate

Harness Dickey Biopharma Patent Law

February 9, 2017

Enhanced Damages for Willful Infringement

By: Damian H. Kotsis, Ph.D., Associate; Jennifer R. Turchyn, Associate

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2020 Harness, Dickey & Pierce, P.L.C. All rights reserved.